Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-12-21

Clinical Trial Update: Ensure Cardiac Resynchronization Therapy Study

View source ↗

Summary

Medtronic's Cardiac Resynchronization Therapy study has completed. The study focused on heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cardiac Resynchronization Therapy device

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure | Status: COMPLETED